Quantcast
Last updated on April 17, 2014 at 8:56 EDT

Latest Heart failure Stories

2013-11-13 23:03:59

Preclinical Testing at Icahn School of Medicine at Mount Sinai Shows SUMO-1 Gene Therapy Shrinks an Enlarged Heart, Improves Heart Function, and Blood Flow New York, NY (PRWEB) November 13, 2013 Researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models. The new research study findings, published in November 13 issue of...

2013-11-12 12:28:25

MONT-SAINT-GUIBERT, Belgium, November 12, 2013 /PRNewswire/ -- Cardio3 BioSciences SA (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, today announces: - A business update for the nine-month period ending 30 September 2013; and - It has received the authorization from the Polish Medicines Agency (URPL) to...

2013-11-12 08:36:51

VIENNA, Va., Nov. 12, 2013 /PRNewswire/ -- Sarfez Pharmaceuticals has completed a trial of its novel loop diuretic drug that has the potential to revolutionize the quality of life and life expectancy of patients suffering from chronic kidney disease, congestive heart failure and resistant hypertension. By adapting an existing drug--Torsemide-- into a much-needed extended release formulation, Sarfez is hoping to give patients resistant to the current diuretics a drug that will support...

2013-11-12 04:22:37

Patrick O'Hara Also is the 1st Indianan to be Implanted with the SynCardia Heart and the 1st Discharged From the Hospital Without a Human Heart, Thanks to the Freedom® Portable Driver TUCSON, Ariz., Nov. 12, 2013 /PRNewswire/ -- An Indiana man has become the 1,200th person in the world to be implanted with the SynCardia temporary Total Artificial Heart. Patrick O'Hara is the first person in Indiana to receive the life-saving device and the first Hoosier to be discharged from the...

2013-11-08 16:24:49

FRAMINGHAM, Mass., Nov. 8, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity Medical Technology & Diagnostics Forum at 1:30 p.m. ET on Thursday, November 14, 2013. The one-day conference is being held at the Westin Grand...

2013-11-07 23:24:53

Abington Memorial Hospital has been recognized for successfully implementing a higher standard of care for heart failure patients through the American Heart Association’s Get With The Guidelines®–Heart Failure quality improvement program. Abington, PA (PRWEB) November 07, 2013 Abington Memorial Hospital, a Gold level recipient, is among 299 hospitals receiving a Get With the Guidelines–Heart Failure award this year. More than 1,000 hospitals received awards for their...

Faulty Enzymes Cause Diabetic Cardiomyopathy
2013-11-07 09:18:20

redOrbit Staff & Wire Reports - Your Universe Online A family of enzymes that controls the functions of other proteins could be the possible cause of heart failure in diabetics, according to new research appearing in the Journal of Biological Chemistry. While many studies have been written on cardiovascular disease and diabetes, little is known about diabetic cardiomyopathy, a disorder of the heart muscle in diabetes patients that can lead to the heart’s inability to effectively...

2013-11-06 23:01:13

First Annual NYC 02 Breathe Gala to Feature MSNBC anchor and NBC News Correspondent Craig Melvin as Master of Ceremonies New York, NY (PRWEB) November 06, 2013 The Pulmonary Hypertension Association’s (PHA) 1st Annual New York City O2 breathe Gala will honor the legacy of Dr. Robyn Barst and will feature 2011 AVON National and International Songwriting Competition Winner, singer-songwriter Chloe Temtchine. Mere months after her diagnosis of pulmonary hypertension (PH) caused by PVOD,...

Scientists Inhibit Heart Protein To Treat Heart Attacks
2013-11-06 19:09:41

Lee Rannals for redOrbit.com – Your Universe Online Scientists have found it is possible to limit the damage caused by intermittent blood flow during and after a heart attack. Experiments on mice helped researchers discover that inhibition of a heart protein called TNNI3K reduced damage from heart attacks and protected the heart from further injury. These findings have significant potential for heart attack patients in a clinical setting. "Many times, what is done in a lab setting...

2013-11-06 11:10:38

Discovery raises prospects for new therapies Some of the most commonly prescribed drugs for the treatment of heart failure are beta-blockers and nitrates, which help to relax blood vessels and decrease the heart's workload. The drugs were thought to produce those effects through distinct molecular pathways, but according to a new study led by scientists at Temple University School of Medicine, both types of drugs may help the failing heart by counteracting the effects of an enzyme known as...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »